WO2005092365A3 - Pharmaceutical use of novispirins - Google Patents
Pharmaceutical use of novispirins Download PDFInfo
- Publication number
- WO2005092365A3 WO2005092365A3 PCT/DK2005/000211 DK2005000211W WO2005092365A3 WO 2005092365 A3 WO2005092365 A3 WO 2005092365A3 DK 2005000211 W DK2005000211 W DK 2005000211W WO 2005092365 A3 WO2005092365 A3 WO 2005092365A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novispirins
- pharmaceutical use
- infections
- novispirin
- preparation
- Prior art date
Links
- 208000032376 Lung infection Diseases 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 206010040872 skin infection Diseases 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400503 | 2004-03-29 | ||
DKPA200400503 | 2004-03-29 | ||
DKPA200401288 | 2004-08-26 | ||
DKPA200401288 | 2004-08-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005092365A2 WO2005092365A2 (en) | 2005-10-06 |
WO2005092365A3 true WO2005092365A3 (en) | 2006-04-27 |
Family
ID=34962014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2005/000211 WO2005092365A2 (en) | 2004-03-29 | 2005-03-29 | Pharmaceutical use of novispirins |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005092365A2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002000839A2 (en) * | 2000-06-28 | 2002-01-03 | The Regents Of The University Of California | Statement as to federally sponsored research |
-
2005
- 2005-03-29 WO PCT/DK2005/000211 patent/WO2005092365A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002000839A2 (en) * | 2000-06-28 | 2002-01-03 | The Regents Of The University Of California | Statement as to federally sponsored research |
Non-Patent Citations (3)
Title |
---|
BARTLETT KAREN H ET AL: "Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection model.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 47, no. 12, December 2003 (2003-12-01), pages 3901 - 3906, XP002351530, ISSN: 0066-4804 * |
SAWAI MONALI V ET AL: "Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides", PROTEIN ENGINEERING, vol. 15, no. 3, March 2002 (2002-03-01), pages 225 - 232, XP002335929, ISSN: 0269-2139 * |
STEINSTRAESSER LARS ET AL: "Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 46, no. 6, June 2002 (2002-06-01), pages 1837 - 1844, XP002351531, ISSN: 0066-4804 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005092365A2 (en) | 2005-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2279662A3 (en) | 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent | |
HK1090843A1 (en) | Pharmaceutical compositions for healing wounds | |
WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
IL199835A (en) | Acid activated antimicrobial peptides, pharmaceutical compositions comprising the same and use thereof for the preparation of medicaments | |
WO2005020896A3 (en) | N,n-dihalogenated amino acids and derivatives | |
WO2006013441A3 (en) | Use of probiotic bacteria for the preparation of topical compositions for skin protection | |
BRPI0810958A2 (en) | "composition, method of curative or preventive control of crop phytopathogenic fungi and use of composition" | |
WO2006087543A8 (en) | Antibacterial piperidine derivatives | |
WO2005034883A3 (en) | A method of healing skin wounds in mammals and a composition therefor | |
WO2007030666A3 (en) | Medicated skin care preparation for promoting wound healing | |
WO2008020227A3 (en) | Antibacterial pyrrolecarboxamides | |
WO2008020229A3 (en) | Antibacterial pyrrolecarboxamides | |
WO2002069945A3 (en) | Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors | |
WO2007071965A3 (en) | Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines | |
UA93709C2 (en) | 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions | |
WO2007051468A3 (en) | Preparation of an antibiotic crystalline fusidic acid | |
WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
CL2007003332A1 (en) | COMPOUNDS DERIVED FROM CONDENSED HETEROCICLES; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE PREVENTION OR TREATMENT OF BACTERIAL INFECTIONS. | |
IL181634A (en) | Topical pharmaceutical compositions comprising 8-pyrazolylmethyl-1,3,7-trihydropurine-2,6-dione derivatives useful for wound healing | |
IL189270A (en) | Phosphonated rifamycins and derivatives thereof, pharmaceutical compositions comprising the same and uses thereof in the preparation of medicaments for the prevention and treatment of bone and joint infections | |
WO2007009701A3 (en) | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome | |
WO2008071961A8 (en) | 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents | |
CL2004001012A1 (en) | COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS | |
WO2006083927A3 (en) | Antimicrobial agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |